Jonathan H. Smith, MD

Associate Medical Director, Physician Development Program, Neuroscience
AbbVie
Irvine, California

Disclosure information not submitted.

Presentation(s):

• Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial

  POSTER ABSTRACT